Tomiyama M
Department of Otolaryngology, Suibaragou Hospital, Niigata.
Nihon Jibiinkoka Gakkai Kaiho. 1995 Apr;98(4):659-68. doi: 10.3950/jibiinkoka.98.659.
Changes in nasopharyngeal flora were investigated in children with acute otitis media and with acute exacerbations of chronic sinusitis in whom antibiotic therapy of relatively long duration was required until substantial improvement in clinical findings was achieved. 1. The antibiotics used were two cephalosporins, i.e., cefaclor (CCL) and cefixime (CFIX), administered to 18 patients each for 1 week and to 26 and 20 patients, respectively, for 2 weeks. Bacteriologic examination of the nasopharyngeal mucosa was performed at the first visit and at 1 week in those who underwent antibiotic therapy for 1 week, and at the first visit and at 1 and 2 weeks in those treated with antibiotics for 2 weeks. 2. The elimination rates for the infecting microorganisms in the patients in the CCL-treated group were 30% for Haemophilus influenzae, 83% for Staphylococcus aureus, 100% for Streptococcus pyogenes and 100% for Streptococcus pneumoniae at 1 week, and 18% for H. influenzae, 100% for S. aureus and 100% for S. pyogenes at 2 weeks of antibiotic therapy. Replacement of S. aureus and S. pyogenes by H. influenzae was observed. 3. The elimination rates for infecting bacteria in the patients in the CFIX-treated groups were 61% for H. influenzae, 50% for S. aureus, 75% for S. pyogenes, 80% for S. pneumoniae and 100% for Moraxella catarrhalis at 1 week, and 72% for H. influenzae, 0% for S. aureus, 100% for S. pyogenes, and 0% for S. pneumoniae at 2 weeks of antibiotic therapy. The elimination rate for H. influenzae at 2 weeks was significantly higher than the corresponding value for the CCL-treated group. Replacement of H. influenzae by S. aureus and S. pneumoniae and of S. pyogenes by S. aureus was detected. 4. There was one patient with acute otitis media in the CFIX-treated group in whom a clinical relapse occurred due to H. influenzae persisters in the nasopharynx. Thus the diagnosis in this patient was so-called "recurrent otitis media". 5. H. influenzae tended to persist after exposure to therapeutically adequate concentrations of CCL, as did S. aureus and S. pneumoniae following treatment with CFIX. Thus, it would seem that ample heed must be given to persistence, particularly of H. influenzae and S. pneumoniae, the most common causative agents of acute otitis media in childhood. 6. A significant rise in the MICs of the cephalosporins was observed in 4 of 43 patients in whom the same type of organism was isolated from the nasopharynx at weekly intervals during antibiotic therapy.(ABSTRACT TRUNCATED AT 400 WORDS)
对患有急性中耳炎和慢性鼻窦炎急性加重的儿童的鼻咽部菌群变化进行了研究,这些儿童需要接受较长时间的抗生素治疗,直至临床症状有显著改善。1. 使用的两种抗生素为头孢克洛(CCL)和头孢克肟(CFIX),分别对18例患者给药1周,对26例和20例患者分别给药2周。在首次就诊时以及接受1周抗生素治疗的患者在治疗1周时、接受2周抗生素治疗的患者在首次就诊时以及治疗1周和2周时对鼻咽部黏膜进行细菌学检查。2. CCL治疗组患者中感染微生物的清除率在抗生素治疗1周时,流感嗜血杆菌为30%,金黄色葡萄球菌为83%,化脓性链球菌为100%,肺炎链球菌为100%;在治疗2周时,流感嗜血杆菌为18%,金黄色葡萄球菌为100%,化脓性链球菌为100%。观察到金黄色葡萄球菌和化脓性链球菌被流感嗜血杆菌取代。3. CFIX治疗组患者中感染细菌的清除率在抗生素治疗1周时,流感嗜血杆菌为61%,金黄色葡萄球菌为50%,化脓性链球菌为75%,肺炎链球菌为80%,卡他莫拉菌为100%;在治疗2周时,流感嗜血杆菌为72%,金黄色葡萄球菌为0%,化脓性链球菌为100%,肺炎链球菌为0%。治疗2周时流感嗜血杆菌的清除率显著高于CCL治疗组的相应值。检测到流感嗜血杆菌被金黄色葡萄球菌和肺炎链球菌取代,化脓性链球菌被金黄色葡萄球菌取代。4. CFIX治疗组有1例急性中耳炎患者因鼻咽部流感嗜血杆菌持续存在而发生临床复发。因此该患者的诊断为所谓的“复发性中耳炎”。5. 流感嗜血杆菌在接触治疗浓度足够的CCL后倾向于持续存在,金黄色葡萄球菌和肺炎链球菌在接受CFIX治疗后也如此。因此,似乎必须充分关注持续性,尤其是儿童急性中耳炎最常见病原体流感嗜血杆菌和肺炎链球菌的持续性。6. 在43例患者中有4例在抗生素治疗期间每周从鼻咽部分离出同一类型的微生物,观察到头孢菌素的最低抑菌浓度显著升高。(摘要截短至400字)